(NYSE: AVNS) Avanos Medical's forecast annual revenue growth rate of 3.47% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 12.43%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,552.9%.
Avanos Medical's revenue in 2026 is $699,900,000.On average, 3 Wall Street analysts forecast AVNS's revenue for 2026 to be $33,616,572,449, with the lowest AVNS revenue forecast at $32,298,275,491, and the highest AVNS revenue forecast at $34,605,295,169.
In 2027, AVNS is forecast to generate $33,995,350,731 in revenue, with the lowest revenue forecast at $32,662,199,721 and the highest revenue forecast at $34,995,213,987.